Publication Topic

Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. 2012. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4:283–301.

Boffetta P, Fryzek JP, Mandel JS. 2012. Occupational exposure to beryllium and cancer risk: A review of the epidemiologic evidence. Crit Rev Toxicol 42(2):107-118.

Kuehn C, Watson H, Ong K, Mohamed M, Ochoa JA, Fryzek J. Descriptive Epidemiology of Medical Device Use among Patients with Breast, Lung or Prostate Cancer in the National Inpatient Sample. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 23-26, 2012, Barcelona, Spain.

Alexander D, Weed D, Mink P, Mitchell M. 2012. A weight-of-evidence review of colorectal cancer in pesticide applicators: The agricultural health study and other epidemiologic studies. Int Arch Occup Environ Health 85(7):715–745.

Fordyce T, Mowat F, Fryzek J, Lau E. Incidence of metastatic hormone receptor positive (HR+) breast cancer in the United Kingdom: Data Needed. Presented at the 17th Annual International Society for Pharacoeconomics and Outcomes Research, June 2-6, 2012, Washington, DC.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 2011

Yong M, Christiansen CF, Gammelager H, Sværke C, Chia V, Atchison C, Fryzek J. Healthcare resource utilization among breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1997 – 2009). Presented at the 34th Annual San Antonio Breast Cancer Symposium, December 6-10, 2011, San Antonio, TX.

Yong M, Jensen AÖ, Jacobsen JB, Nørgaard M, Fryzek JP, Sørensen HT. 2011. Survival in breast cancer patients with bone metastases and skeletal-related events: A population-based cohort study in Denmark (1999-2007). Breast Cancer Res Treat 129(2):495-503.

Lau EC, Mowat FS, Kelsh MA, Legg JC, Engel-Nitz NM, Watson HN, et al. 2011. Use of electronic medical records (EMR) for oncology outcomes research: Assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol 3:259–272.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastases among breast, lung, and prostate cancer patients. Presented at the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 2011.